| Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature genetics 45 (9), 984-994, 2013 | 2345 | 2013 |
| Genome-wide association study identifies 30 loci associated with bipolar disorder EA Stahl, G Breen, AJ Forstner, A McQuillin, S Ripke, V Trubetskoy, ... Nature genetics 51 (5), 793-803, 2019 | 1402 | 2019 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1370 | 2018 |
| European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD SJJ Kooij, S Bejerot, A Blackwell, H Caci, M Casas-Brugué, PJ Carpentier, ... BMC psychiatry 10, 1-24, 2010 | 1212 | 2010 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1061 | 2019 |
| Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis M Hoogman, J Bralten, DP Hibar, M Mennes, MP Zwiers, LSJ Schweren, ... The Lancet Psychiatry 4 (4), 310-319, 2017 | 937 | 2017 |
| The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder SV Faraone, T Banaschewski, D Coghill, Y Zheng, J Biederman, ... Neuroscience & biobehavioral reviews 128, 789-818, 2021 | 868 | 2021 |
| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 828 | 2021 |
| Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan B Franke, G Michelini, P Asherson, T Banaschewski, A Bilbow, ... European Neuropsychopharmacology 28 (10), 1059-1088, 2018 | 631 | 2018 |
| Updated European Consensus Statement on diagnosis and treatment of adult ADHD JJS Kooij, D Bijlenga, L Salerno, R Jaeschke, I Bitter, J Balazs, J Thome, ... European psychiatry 56 (1), 14-34, 2019 | 592 | 2019 |
| The genetics of attention deficit/hyperactivity disorder in adults, a review B Franke, SV Faraone, P Asherson, J Buitelaar, CHD Bau, ... Molecular psychiatry 17 (10), 960-987, 2012 | 539 | 2012 |
| Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes DM Ruderfer, S Ripke, A McQuillin, J Boocock, EA Stahl, JMW Pavlides, ... Cell 173 (7), 1705-1715. e16, 2018 | 527 | 2018 |
| Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature neuroscience 18 (2), 199-209, 2015 | 524 | 2015 |
| GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability JA Pasman, KJH Verweij, Z Gerring, S Stringer, S Sanchez-Roige, ... Nature neuroscience 21 (9), 1161-1170, 2018 | 429 | 2018 |
| Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples M Hoogman, R Muetzel, JP Guimaraes, E Shumskaya, M Mennes, ... American Journal of Psychiatry 176 (7), 531-542, 2019 | 374 | 2019 |
| A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication M Arcos-Burgos, M Jain, MT Acosta, S Shively, H Stanescu, D Wallis, ... Molecular psychiatry 15 (11), 1053-1066, 2010 | 339 | 2010 |
| Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium XZ Kong, SR Mathias, T Guadalupe, ENIGMA Laterality Working Group, ... Proceedings of the National Academy of Sciences 115 (22), E5154-E5163, 2018 | 335 | 2018 |
| Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults X Castells, L Blanco‐Silvente, R Cunill Cochrane Database of Systematic Reviews, 2018 | 273 | 2018 |
| Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review P Molero, JA Ramos-Quiroga, R Martin-Santos, E Calvo-Sánchez, ... CNS drugs 32, 411-420, 2018 | 252 | 2018 |
| A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder R Medori, JA Ramos-Quiroga, M Casas, JJS Kooij, A Niemelä, GE Trott, ... Biological psychiatry 63 (10), 981-989, 2008 | 239 | 2008 |
